OMNITIDE Trademark

Trademark Overview

On Tuesday, July 7, 2026, a trademark application was filed for OMNITIDE with the United States Patent and Trademark Office. The USPTO has given the OMNITIDE trademark a serial number of 99925734. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 7, 2026. This trademark is owned by Crystal Bioscience, Inc.. The OMNITIDE trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

synthesized peptides for medical use, namely, for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; biological reagents for medical use; chemical reagents for medical use, namely, for the detection, measurement and identification of genetic materials; biological tissue cultures, namely, animal tissue cultures for medical purposes; radiopharmaceutical compositions for medical diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides for use in drug discovery of pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer,...

synthesized peptides for scientific and research use; for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research, product development, and manufacture of pharmaceuticals; chemical reagents for use in evaluating genetic material, namely, the detection, measurement and identification of genetic materials and their compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use

manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others

Scientific research services in the field of the analysis and synthesis of peptides; Scientific research services in the field of the analysis and synthesis of proteins; quality control of peptides used in drug development; advice on quality control of peptides used in drug development; scientific research and development; scientific research and development in the field of immunization
omnitide

General Information

Serial Number99925734
Word MarkOMNITIDE
Filing DateTuesday, July 7, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, July 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicessynthesized peptides for medical use, namely, for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; biological reagents for medical use; chemical reagents for medical use, namely, for the detection, measurement and identification of genetic materials; biological tissue cultures, namely, animal tissue cultures for medical purposes; radiopharmaceutical compositions for medical diagnostic or therapeutic use, namely, diagnostic radiopharmaceutical preparations and radiopharmaceuticals for the diagnosis or treatment of cancer, cardiovascular disease, lung disease, thyroid disease, bone disease, brain disease, and bodily tissue disease; synthesized peptides for use in drug discovery of pharmaceuticals for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; chemical preparations for use in drug discovery for the treatment of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain; pharmaceutical preparations for use in the treatment of medical conditions, namely, suppressing tumors; diagnostic preparations for medical purposes; pharmaceutical preparations in the nature of synthesized peptides for use in drug discovery and pharmaceuticals for the treatment of medical purposes; synthesized proteins and chemical preparations for use in drug discovery and pharmaceuticals for the treatment of of viral, respiratory, autoimmune, immune, inflammatory, dermatological, endocrine, heptalogical, metabolic, infectious diseases and disorders, cancer, and pain
Goods and Servicessynthesized peptides for scientific and research use; for research purposes, excluding those for medical or veterinary use; proteins and synthesized peptides used in the research, product development, and manufacture of pharmaceuticals; chemical reagents for use in evaluating genetic material, namely, the detection, measurement and identification of genetic materials and their compounds, excluding those for medical and veterinary use; biological tissue, namely, animal tissue for use in scientific and medical research; cells for scientific and research use; stem cells for scientific and research use
Goods and Servicesmanufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others
Goods and ServicesScientific research services in the field of the analysis and synthesis of peptides; Scientific research services in the field of the analysis and synthesis of proteins; quality control of peptides used in drug development; advice on quality control of peptides used in drug development; scientific research and development; scientific research and development in the field of immunization

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2026
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCrystal Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
US

Trademark Events

Event DateEvent Description
Tuesday, July 7, 2026NEW APPLICATION ENTERED
Tuesday, July 7, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

omnitide research peptides scientific medical namely disease development tissue synthesized biological